Procter Gamble stock edges higher as Q4 revenue rises 24%; Motilal Oswal sees 18% upside
Procter & Gamble Q1 results: While valuations at 44.3x FY23E EPS are in line with staples peers, the company has a stronger topline and earnings track record, best-of-breed structural earnings growth potential, Motilal Oswal said. Procter & Gamble Hygiene & Health Care | The company reported profit at Rs 48.98 crore in Q4FY21 against Rs […]
Continue Reading